360 related articles for article (PubMed ID: 33431814)
21. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
22. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X
Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285
[TBL] [Abstract][Full Text] [Related]
23. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
World J Surg Oncol; 2019 Jun; 17(1):97. PubMed ID: 31170995
[TBL] [Abstract][Full Text] [Related]
24. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma.
Chen H; Zhou XH; Li JR; Zheng TH; Yao FB; Gao B; Xue TC
Cancer Lett; 2021 Dec; 522():22-31. PubMed ID: 34517084
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral heterogeneity and clonal evolution in liver cancer.
Losic B; Craig AJ; Villacorta-Martin C; Martins-Filho SN; Akers N; Chen X; Ahsen ME; von Felden J; Labgaa I; DʹAvola D; Allette K; Lira SA; Furtado GC; Garcia-Lezana T; Restrepo P; Stueck A; Ward SC; Fiel MI; Hiotis SP; Gunasekaran G; Sia D; Schadt EE; Sebra R; Schwartz M; Llovet JM; Thung S; Stolovitzky G; Villanueva A
Nat Commun; 2020 Jan; 11(1):291. PubMed ID: 31941899
[TBL] [Abstract][Full Text] [Related]
26. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
[TBL] [Abstract][Full Text] [Related]
27. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication.
Nishida N; Kudo M
Oncology; 2017; 92 Suppl 1():40-49. PubMed ID: 27764823
[TBL] [Abstract][Full Text] [Related]
28. Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment.
Wang YF; Yuan SX; Jiang H; Li ZX; Yin HZ; Tan J; Dai ZH; Ge CM; Sun SH; Yang F
Theranostics; 2022; 12(9):4163-4180. PubMed ID: 35673582
[No Abstract] [Full Text] [Related]
29. The immune contexture of hepatocellular carcinoma predicts clinical outcome.
Foerster F; Hess M; Gerhold-Ay A; Marquardt JU; Becker D; Galle PR; Schuppan D; Binder H; Bockamp E
Sci Rep; 2018 Mar; 8(1):5351. PubMed ID: 29599491
[TBL] [Abstract][Full Text] [Related]
30. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.
Zhang Q; Lou Y; Yang J; Wang J; Feng J; Zhao Y; Wang L; Huang X; Fu Q; Ye M; Zhang X; Chen Y; Ma C; Ge H; Wang J; Wu J; Wei T; Chen Q; Wu J; Yu C; Xiao Y; Feng X; Guo G; Liang T; Bai X
Gut; 2019 Nov; 68(11):2019-2031. PubMed ID: 31227589
[TBL] [Abstract][Full Text] [Related]
31. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
32. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
Zhang Q; He Y; Luo N; Patel SJ; Han Y; Gao R; Modak M; Carotta S; Haslinger C; Kind D; Peet GW; Zhong G; Lu S; Zhu W; Mao Y; Xiao M; Bergmann M; Hu X; Kerkar SP; Vogt AB; Pflanz S; Liu K; Peng J; Ren X; Zhang Z
Cell; 2019 Oct; 179(4):829-845.e20. PubMed ID: 31675496
[TBL] [Abstract][Full Text] [Related]
33. High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients.
He X; Qu F; Zhou F; Zhou X; Chen Y; Guo X; Li J; Huang Q; Yang Y; Lyu Z; Zhang H; Xing J
Oncotarget; 2016 Apr; 7(16):22834-45. PubMed ID: 26985767
[TBL] [Abstract][Full Text] [Related]
34. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2020 Jul; 26(26):3720-3736. PubMed ID: 32774053
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
37. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
38. Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study.
Zhai W; Lai H; Kaya NA; Chen J; Yang H; Lu B; Lim JQ; Ma S; Chew SC; Chua KP; Alvarez JJS; Chen PJ; Chang MM; Wu L; Goh BKP; Chung AY; Chan CY; Cheow PC; Lee SY; Kam JH; Kow AW; Ganpathi IS; Chanwat R; Thammasiri J; Yoong BK; Ong DB; de Villa VH; Dela Cruz RD; Loh TJ; Wan WK; Zeng Z; Skanderup AJ; Pang YH; Madhavan K; Lim TK; Bonney G; Leow WQ; Chew V; Dan YY; Tam WL; Toh HC; Foo RS; Chow PK
Natl Sci Rev; 2022 Mar; 9(3):nwab192. PubMed ID: 35382356
[TBL] [Abstract][Full Text] [Related]
39. Trajectory of immune evasion and cancer progression in hepatocellular carcinoma.
Nguyen PHD; Wasser M; Tan CT; Lim CJ; Lai HLH; Seow JJW; DasGupta R; Phua CZJ; Ma S; Yang J; Suthen SD; Tam WL; Lim TKH; Yeong J; Leow WQ; Pang YH; Soon G; Loh TJ; Wan WK; Chan CY; Cheow PC; Toh HC; Kow A; Dan YY; Kam JH; Iyer S; Madhavan K; Chung A; Bonney GK; Goh BKP; Fu N; Yu VC; Zhai W; Albani S; Chow PKH; Chew V
Nat Commun; 2022 Mar; 13(1):1441. PubMed ID: 35301339
[TBL] [Abstract][Full Text] [Related]
40. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma.
Xu FQ; Dong MM; Wang ZF; Cao LD
Front Immunol; 2023; 14():1083069. PubMed ID: 36776894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
